Dr Haifer conducts an active research portfolio in the field of faecal microbiota transplantation and is using this platform to develop next generation microbial therapeutics.
Securing part of this $3m grant program reflects the state's commitment to becoming a global centre of excellence in advanced therapeutics research, with a particular focus on microbiomics and its impact on human health.
Dr. Haifer, specialist gastroenterologist, is leading the world's first study on capsule-based faecal microbiota transplantation for cancer therapy patients, playing a crucial role in expanding the accessibility of this treatment method across Australia.
